1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cardiovascular Magnetic Resonance Imaging (MRI) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cardiovascular Magnetic Resonance Imaging (MRI) by Country/Region, 2020, 2024 & 2031
2.2 Cardiovascular Magnetic Resonance Imaging (MRI) Segment by Type
2.2.1 Open MRI
2.2.2 Closed MRI
2.3 Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Type
2.3.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2020-2025)
2.3.2 Global Cardiovascular Magnetic Resonance Imaging (MRI) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cardiovascular Magnetic Resonance Imaging (MRI) Sale Price by Type (2020-2025)
2.4 Cardiovascular Magnetic Resonance Imaging (MRI) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Diagnostic Imaging Center
2.4.4 Other
2.5 Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Application
2.5.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Sale Market Share by Application (2020-2025)
2.5.2 Global Cardiovascular Magnetic Resonance Imaging (MRI) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cardiovascular Magnetic Resonance Imaging (MRI) Sale Price by Application (2020-2025)
3 Global Cardiovascular Magnetic Resonance Imaging (MRI) by Company
3.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Breakdown Data by Company
3.1.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Annual Sales by Company (2020-2025)
3.1.2 Global Cardiovascular Magnetic Resonance Imaging (MRI) Sales Market Share by Company (2020-2025)
3.2 Global Cardiovascular Magnetic Resonance Imaging (MRI) Annual Revenue by Company (2020-2025)
3.2.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Revenue by Company (2020-2025)
3.2.2 Global Cardiovascular Magnetic Resonance Imaging (MRI) Revenue Market Share by Company (2020-2025)
3.3 Global Cardiovascular Magnetic Resonance Imaging (MRI) Sale Price by Company
3.4 Key Manufacturers Cardiovascular Magnetic Resonance Imaging (MRI) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiovascular Magnetic Resonance Imaging (MRI) Product Location Distribution
3.4.2 Players Cardiovascular Magnetic Resonance Imaging (MRI) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cardiovascular Magnetic Resonance Imaging (MRI) by Geographic Region
4.1 World Historic Cardiovascular Magnetic Resonance Imaging (MRI) Market Size by Geographic Region (2020-2025)
4.1.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cardiovascular Magnetic Resonance Imaging (MRI) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cardiovascular Magnetic Resonance Imaging (MRI) Market Size by Country/Region (2020-2025)
4.2.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cardiovascular Magnetic Resonance Imaging (MRI) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cardiovascular Magnetic Resonance Imaging (MRI) Sales Growth
4.4 APAC Cardiovascular Magnetic Resonance Imaging (MRI) Sales Growth
4.5 Europe Cardiovascular Magnetic Resonance Imaging (MRI) Sales Growth
4.6 Middle East & Africa Cardiovascular Magnetic Resonance Imaging (MRI) Sales Growth
5 Americas
5.1 Americas Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Country
5.1.1 Americas Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025)
5.1.2 Americas Cardiovascular Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025)
5.2 Americas Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Type
5.3 Americas Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Region
6.1.1 APAC Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Region (2020-2025)
6.1.2 APAC Cardiovascular Magnetic Resonance Imaging (MRI) Revenue by Region (2020-2025)
6.2 APAC Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Type
6.3 APAC Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cardiovascular Magnetic Resonance Imaging (MRI) by Country
7.1.1 Europe Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025)
7.1.2 Europe Cardiovascular Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025)
7.2 Europe Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Type
7.3 Europe Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cardiovascular Magnetic Resonance Imaging (MRI) by Country
8.1.1 Middle East & Africa Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cardiovascular Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025)
8.2 Middle East & Africa Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Type
8.3 Middle East & Africa Cardiovascular Magnetic Resonance Imaging (MRI) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiovascular Magnetic Resonance Imaging (MRI)
10.3 Manufacturing Process Analysis of Cardiovascular Magnetic Resonance Imaging (MRI)
10.4 Industry Chain Structure of Cardiovascular Magnetic Resonance Imaging (MRI)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cardiovascular Magnetic Resonance Imaging (MRI) Distributors
11.3 Cardiovascular Magnetic Resonance Imaging (MRI) Customer
12 World Forecast Review for Cardiovascular Magnetic Resonance Imaging (MRI) by Geographic Region
12.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Market Size Forecast by Region
12.1.1 Global Cardiovascular Magnetic Resonance Imaging (MRI) Forecast by Region (2026-2031)
12.1.2 Global Cardiovascular Magnetic Resonance Imaging (MRI) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cardiovascular Magnetic Resonance Imaging (MRI) Forecast by Type
12.7 Global Cardiovascular Magnetic Resonance Imaging (MRI) Forecast by Application
13 Key Players Analysis
13.1 General Electric Company
13.1.1 General Electric Company Company Information
13.1.2 General Electric Company Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.1.3 General Electric Company Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 General Electric Company Main Business Overview
13.1.5 General Electric Company Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.2.3 Medtronic Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Koninklijke Philips N.V
13.3.1 Koninklijke Philips N.V Company Information
13.3.2 Koninklijke Philips N.V Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.3.3 Koninklijke Philips N.V Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Koninklijke Philips N.V Main Business Overview
13.3.5 Koninklijke Philips N.V Latest Developments
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Information
13.4.2 Siemens Healthcare Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.4.3 Siemens Healthcare Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Siemens Healthcare Main Business Overview
13.4.5 Siemens Healthcare Latest Developments
13.5 Canon Medical Systems Corporation
13.5.1 Canon Medical Systems Corporation Company Information
13.5.2 Canon Medical Systems Corporation Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.5.3 Canon Medical Systems Corporation Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Canon Medical Systems Corporation Main Business Overview
13.5.5 Canon Medical Systems Corporation Latest Developments
13.6 Bruker
13.6.1 Bruker Company Information
13.6.2 Bruker Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.6.3 Bruker Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bruker Main Business Overview
13.6.5 Bruker Latest Developments
13.7 Hitachi Medical Systems
13.7.1 Hitachi Medical Systems Company Information
13.7.2 Hitachi Medical Systems Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.7.3 Hitachi Medical Systems Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hitachi Medical Systems Main Business Overview
13.7.5 Hitachi Medical Systems Latest Developments
13.8 Mindray
13.8.1 Mindray Company Information
13.8.2 Mindray Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.8.3 Mindray Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mindray Main Business Overview
13.8.5 Mindray Latest Developments
13.9 Neusoft Medical Systems
13.9.1 Neusoft Medical Systems Company Information
13.9.2 Neusoft Medical Systems Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.9.3 Neusoft Medical Systems Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Neusoft Medical Systems Main Business Overview
13.9.5 Neusoft Medical Systems Latest Developments
13.10 Ningbo Jansen NMR Technology
13.10.1 Ningbo Jansen NMR Technology Company Information
13.10.2 Ningbo Jansen NMR Technology Cardiovascular Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications
13.10.3 Ningbo Jansen NMR Technology Cardiovascular Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ningbo Jansen NMR Technology Main Business Overview
13.10.5 Ningbo Jansen NMR Technology Latest Developments
14 Research Findings and Conclusion
※参考情報 心血管用磁気共鳴画像法(MRI)は、心臓や血管の構造と機能を評価するための非侵襲的な画像診断技術です。MRIは強力な磁場と高周波のパルスを用いて、体内の水分子の挙動を観察し、詳細な画像を生成します。この技術は、心臓に関する様々な病態を診断するために非常に役立ちます。心血管MRIは、臨床での応用範囲が広く、心臓病の診断や治療の計画、さらには経過観察に使用されています。 心血管MRIの特徴の一つは、その優れた解像度です。特に心筋の立体構造や血流の動態を詳細に観察できる点で、他の画像診断法と比較して突出した性能を持っています。また、放射線を使用せずに多様な撮影が可能なため、患者に与える負担が少なく、特に若年患者や再検査が必要な患者にとって有益です。 心血管MRIにはいくつかの種類があり、主に以下のような手法が用いられます。まず、心臓の解剖学的構造を撮影するための「解剖的MRI」があります。この手法では、心筋の厚さや心臓の各部位の形状を評価することができます。次に、心臓の機能を評価する「機能的MRI」があります。この技術は、心臓の収縮や拡張の過程をリアルタイムで観察することが可能です。さらに、「 perfusion MRI」では、心筋への血流の状態を評価でき、虚血性心疾患の診断に役立ちます。 心血管MRIの用途は幅広く、一般的な心疾患の診断から、心筋炎、心筋症、先天性心疾患、動脈硬化症などの特定の病態の評価まで多岐にわたります。特に、心筋の瘢痕を評価するための「Late Gadolinium Enhancement MRI」という手法は、心筋の過去の損傷や炎症を視覚化するために非常に効果的です。また、心臓手術の前後の評価や新しい治療法の効果をモニタリングするためにも活用されます。 心血管MRIの関連技術として、心電図(ECG)との組み合わせがあります。心電図は心臓の電気的活動を記録するもので、MRIと組み合わせることで心拍数や心拍リズムに基づいたタイミングでの画像取得が可能となるため、動きの影響を軽減できます。また、画像処理技術の進歩により、MR画像から得られるデータを三次元的に再構築することができるため、より精密な診断が可能となります。 さらに、MRI造影剤として使用されるガドリニウムベースの薬剤は、血管の描出を明確にし、病変を特定するのに役立ちます。造影剤を用いることで、心筋の血流や構造的変化をより一層明確に確認することができます。しかし、これらの造影剤にはアレルギーのリスクや腎機能に対する影響があるため、使用時には慎重な判断が必要です。 心血管用MRIは、心臓病の診断の新たなスタンダードとして確立されています。その精度と信頼性は、臨床の現場において広く支持され、多くの研究でもその有効性が示されています。MRIの特長として、放射線を使用しない点に加え、豊富な組織コントラストにより、脂肪、筋肉、血液など様々な構造を明確に描出できる点も注目すべきです。 技術の進歩に伴い、心血管MRIは今後もさらに革新が予想されます。特に、人工知能(AI)の導入により、画像解析がより迅速かつ正確に行えるようになると期待されています。また、インターベンションとの統合が進むことで、リアルタイムのモニタリングと治療が可能になるなど、将来的には新しい治療法や診断法の開発につながる可能性があります。 結論として、心血管用磁気共鳴画像法(MRI)は、心臓病の診断や治療において非常に重要な役割を果たしており、その特性や応用範囲の広さから、臨床での利用は今後ますます増加していくと考えられます。非侵襲的でありながら高い診断精度を有するこの技術は、心血管領域における革新の一翼を担っており、今後の進展にも大いに期待が寄せられています。心血管MRIは、心臓病の早期発見や社会的な健康増進に寄与するための重要な手段であり、今後もその研究と実用の深化が求められます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/